I also think that. The paragraph exclusively talks about an expected delay to completion of enrolment and then states they are going to make "an amendment" to the protocol (as in one change)
https://clinicaltrials.gov/ct2/show/NCT05506215
Brief Summary:
The study will evaluate the efficacy of SynPath™, a synthetic dermal matrix, in the treatment of diabetic foot ulcers in subjects with diabetes mellitus versus Standard of Care treatment.
Half the subjects with be treated using SynPath™ while the other half will receive Standard of Care treatment
Condition or disease Intervention/treatment Phase 1 Diabetic Foot Chronic Foot Ulcer Wound Healing Foot Ulcer Device: SynPath Acellular Dermal Matrix plus Off-loading Device Device: Wound Dressing composed of 90% collagen and 10% Alginate plus Off-loading Device Not Applicable
mce-anchor
mce-anchorDetailed Description:
One hundred and thirty-eight (138) subjects with chronic Diabetic Foot Ulcers ranging in size from 1cm2 to 25cm2 will be randomized 1:1 to either SynPath™ or Standard of Care after the completion of a 14 day screening/run-in period. Following the of run-in period the subjects with a 'hard to heal' or chronic, (>4 weeks) nonresponsive Wagner Grade 1 or 2 diabetic foot ulcer will be randomized to receive either SynPath™ or SOC treatment. Both treatment groups will require subjects to use off-loading device.
mce-anchorStudy Design
Go to
Study Type : Interventional (Clinical Trial) 1 Estimated Enrollment : 138 participants 2 Allocation: Randomized 3 Intervention Model: Parallel Assignment 4 Masking: None (Open Label) 5 Primary Purpose: Treatment 6 Official Title: A Prospective, Multicenter, Open Label, Randomized, Controlled Clinical Study Evaluating the Effect of NovoSorb ® SynPath™ Dermal Matrix Compared to Standard of Care (SOC) In the Treatment of Nonresponsive, Chronic Diabetic Foot Ulcers. 7 Actual Study Start Date : July 10, 2022 8 Estimated Primary Completion Date : June 1, 2023 9 Estimated Study Completion Date : October 1, 2023
- Forums
- ASX - By Stock
- PNV
- Ann: Update - SynPath Diabetic Foot Ulcer Trial
Ann: Update - SynPath Diabetic Foot Ulcer Trial, page-12
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.61 |
Change
0.090(3.57%) |
Mkt cap ! $1.801B |
Open | High | Low | Value | Volume |
$2.59 | $2.66 | $2.58 | $3.183M | 1.217M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19229 | $2.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.62 | 3084 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15952 | 2.610 |
2 | 1339 | 2.600 |
1 | 1945 | 2.570 |
1 | 5859 | 2.560 |
1 | 1636 | 2.550 |
Price($) | Vol. | No. |
---|---|---|
2.620 | 1636 | 1 |
2.630 | 3333 | 2 |
2.640 | 1636 | 1 |
2.650 | 19763 | 3 |
2.660 | 26946 | 5 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |